- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03147781
Auricular Therapy for Postpartum Lactation
The Effect of Auricular Therapy on Lactation: A Pilot Study
Study Overview
Status
Intervention / Treatment
Detailed Description
Breastfeeding has been of major concern in maternal-child healthcare. Challenges posed by cesarean delivery can have negative impacts on breastfeeding. Efforts to facilitate, support, and sustain breastfeeding have been investigated to a great extent by researchers from a variety of disciplines. In the field of Traditional Chinese Medicine (TCM), a number of clinical studies have been carried out to study the effect of auricular therapy (AT) on postpartum lactation over the years. Limitations in the evidence that currently exists include the lack of randomization, sham-controlled treatment, blinding and/or no valid outcome measures. Given that such information is important for maternal-child health and clinical practice, the study has set out to conduct a pilot trial which employs randomized, single-blinded, and sham group design that examines relevant outcomes using valid measurement.
A total of 96 post cesarean participants have been randomly assigned to one of three treatment conditions: (1) standard care (n=32); (2) standard care with Medulla Junci adhesive on auricular acupoints (n=32); (3) standard care with magnetic pellets adhesive on auricular acupoints (n=32). The standard care group participants only received the standard post cesarean care of the study hospital without any additional therapies. The same set of six pre-specified auricular points were adopted for both Medulla Junci and magnetic pellets groups. The treatment was initiated within 4 to 8 hours post cesarean for 96 hours during their hospital stay at a maternal hospital in Kaohsiung, Taiwan.
Milk production and onset of lactogenesis II have been used as primary outcome variables for the evaluation of the effectiveness of AT. Milk production is determined by the summed value of infant test weighing measurements and expressed breast milk. Maternal perceptions of breast fullness, swelling, leakage, or tingling are the indicator of onset of lactogenesis II. The secondary outcome measures are infant behaviors of observed swallowing and rooting during breastfeeding, neonatal weight gain, and frequencies of urination and defecation of the infant.
Numeric rating scales have been used to measure the effect of the possible mediating variables, i.e., pain and stress. Potential confounding variables have been controlled by either stratified randomization and exclusion criteria or monitored during the study period. Treatment expectation and satisfaction toward AT have been assessed in order to examine their relationship with therapy outcomes. Main components of study feasibility, i.e., recruitment, retention, and acceptance, have been evaluated. Participants also have been contacted to acquire their one and three-month breastfeeding practice status.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kaohsiung, Taiwan, 831
- Love Saint Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Mothers and their term (37-42 weeks) and singleton infants
- Has cesarean section at the study hospital, irrespective of the reason for cesarean (primary, repeated, indicated, elective, scheduled, unscheduled, emergency, or non-emergency)
- Intent to stay hospitalized for at least 96 hours after birth
- Intent to breastfeed
- Able to communicate with Chinese, Taiwanese, or English
Exclusion Criteria:
- Mothers and their preterm infants (<37 weeks), postterm infants (>42weeks)
- Infants who are not able to be breastfed
- Acute and chronic maternal health problems that can affect lactation. 3.1 Acute illness and infections: e.g. tuberculosis, Group B Streptococcus, Methicillin-Resistant Staphylococcus Aureus (MRSA), etc. 3.2 Alternations in endocrine and metabolic functioning: hypothyroidism, hypopituitarism, diabetes, Sheenhan's syndrome, gestational ovarian theca lutein cysts, polycystic ovarian syndrome. 3.3 Breast-related problems, e.g., breast surgery, injury, and cancer, etc. 3.4 Perinatal conditions: placental retention, dysfunctional uterine bleeding.
- Skin conditions in the ear such as rashes, moles, scars, irritation or ear abrasions.
- Has an implanted electrical device (for example, a pacemaker).
- Has earrings on the selected auricular acupoints.
- Had been receiving auricular therapy within the past six months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Standard care
Participants in this group only receive standard post-cesarean care of the study hospital.
It includes mobility restraint, foley retention, IV fluid infusion, oral intake instructions, oral pain medications routine, and breastfeeding practice.
|
|
SHAM_COMPARATOR: Sham AT with Medulla Junci
Participants in this group receive auricular tape with Medulla Junci in addition to standard post-cesarean care during the early 96 postpartum hours.
|
Medulla Junci segments are crumbled into ball-shape and then attached to the pre-selected auricular acupoints with tape.
The treatment was initiated within 4 to 8 hours post cesarean for 96 hours during the hospital stay.
|
EXPERIMENTAL: True AT with magnetic pellets
Participants in this group receive auricular tape with magnetic pellets in addition to standard post-cesarean care during the early 96 postpartum hours.
|
Magnetic pellets are affixed onto pre-selected auricular acupoints with tape.The treatment was initiated within 4 to 8 hours post cesarean for 96 hours during the hospital stay.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Onset of lactogenesis II
Time Frame: up to five postpartum days
|
Maternal perception of breast symptoms of lactation, i.e., breast fullness, swelling, leakage, or tingling, are employed in identifying onset of lactogenesis II.
Assessment of maternal perception began within 4 to 8 hours postpartum.
Participants was instructed to record the approximate time when breast symptoms of lactation first noticed.
They was interviewed regarding these breast symptoms twice daily during their hospital stay.
|
up to five postpartum days
|
Change of Milk production
Time Frame: first five postpartum days
|
Milk production is determined by the summed value of infant test weighing measurements and expressed breast milk.
Test weighing procedure, whereby the infant is weighted under exactly the same clothing and diaper immediately before and after feeding to estimate milk intake during breastfeeding.
|
first five postpartum days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neonatal behaviors of swallowing and rooting during breastfeeding.
Time Frame: first five postpartum days
|
Infants were observed by the study assessor during breastfeeding once daily.
The result obtained from this outcome will assist the evaluation of milk production change.
|
first five postpartum days
|
Neonatal weight
Time Frame: first five postpartum days
|
The data were collected from the nursery record.The result obtained from this outcome will assist the evaluation of milk production change.
|
first five postpartum days
|
Frequencies of urination and defecation
Time Frame: first five postpartum days
|
The data were collected from the nursery record.The result obtained from this outcome will assist the evaluation of milk production change.
|
first five postpartum days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lorna KP Suen, Ph.D, The Hong Kong Polytechnic University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HSEARS20170214003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean
-
Charite University, Berlin, GermanyCompletedCesarean Section Complications | Cesarean Delivery Affecting Newborn | Cesarean Delivery Affecting FetusGermany
-
Ataturk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Ataturk UniversityCompletedCesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedPregnancy | Repeat Cesarean Section | Vaginal Births After CesareanUnited States
-
Uludag UniversityUnknownCesarean Section Complications | Cesarean Wound Disruption | Cesarean Wound; DehiscenceTurkey
-
The First Affiliated Hospital with Nanjing Medical...RecruitingVaginal Birth After Cesarean | Trial of Labor After Cesarean | Spontaneous LaborChina
-
Piazza della Vittoria 14 Studio Medico - Ginecologia...CompletedCesarean Section Complications | Cesarean Wound; DehiscenceItaly
-
Kocaeli UniversityCompletedCesarean Section; Dehiscence | Cesarean Wound; DehiscenceTurkey
Clinical Trials on Sham AT with Medulla Junci
-
Medical Corps, Israel Defense ForceCompletedMotion Sickness | Seasickness | Habituation | Vestibular Time Constant
-
Actegy Ltd.TerminatedCystic FibrosisUnited Kingdom
-
University of BrasiliaUniversity of BurgundyCompletedElectrical StimulationBrazil
-
Holland Bloorview Kids Rehabilitation HospitalRecruiting
-
The Hong Kong Polytechnic UniversityCompletedBreast Neoplasms | Nausea | VomitingChina
-
Henry Ford Health SystemWayne State UniversityRecruiting
-
Ajman UniversityUniversitat Internacional de CatalunyaActive, not recruitingPost Operative Pain | Endodontically Treated TeethUnited Arab Emirates
-
Beijing HospitalUnknownCerebrovascular DiseaseChina
-
Augusta UniversityRecruiting
-
Thorsten RudroffCompletedParkinson Disease | Brain Stimulation | CerebellumUnited States